Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN)
CAPS Rating:
A biotechnology company working to develop and deliver life-changing drug therapies for patients with serious and life-threatening medical conditions.
A biotechnology company working to develop and deliver life-changing drug therapies for patients with serious and life-threatening medical conditions.
Recs
Price and expectations are way too high. This is really a small cap company that's barely gotten started. But it's being valued like a reliable big pharma company.